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The	STOPBANG	Questionnaire	as	a	Screening	Tool	for	Obstructive	
Sleep	Apnoea	in	Pregnancy	
Abstract	
Study Objectives 
We examined the validity of the STOPBANG questionnaire and a modified 
STOPBANG to screen for obstructive sleep apnea (OSA) in obese women during the 
second trimester of pregnancy. 
 
Methods 
Ninety-nine pregnant women aged ≥18 years with body mass index ≥40 kg/m2 
completed the STOPBANG questionnaire during their second trimester. The number 
of oxygen desaturation events (≥4% from baseline) was measured using overnight 
pulse oximetry, with OSA defined as ≥5 events/hour. A Modified STOPBANG score 
was derived by replacing the ‘Tired’ item with Epworth score ≥10. Seven candidate 
models were compared using information theoretic criteria: STOPBANG, Modified 
STOPBANG and individual STOPBANG items (Snore, Tired, Observed to stop 
breathing, high blood Pressure and Neck circumference). We used penalised logistic 
regression and negative binomial regression to derive predicted probabilities of 
having OSA and the predicted total event counts. 
 
Results 
The predicted probability of meeting oximetry criteria for OSA increased with higher 
STOPBANG scores, from <10% for a score <3 to 68% with a score of 6. The total 
number of disordered breathing events was 1.26 (95% CI 1.06 to 1.50) times greater 
for a 1-unit increase in STOPBANG. Of the candidate models, the best relative fit 
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was the Snore item followed by STOPBANG score (essentially equivalent).  The 
predicted probability of having OSA was 5.0% for no snoring and 26.4% for snoring.  
 
Conclusions 
STOPBANG has been shown to be a useful screening tool for OSA in obese 
pregnant women; however the snoring question alone might be a simpler, effective 
predictor.  
 
Key words: 
OSA, Sleep Apnoea, Pregnancy, STOPBANG, Obesity, Snoring.  
 
 
Brief	Summary	
Current Knowledge/Study Rationale:  
Undiagnosed obstructive sleep apnoea in pregnancy can result in maternal and 
neonatal complications.  In this study we evaluated the use of the STOPBANG 
questionnaire to predict OSA in class III obese women during their second trimester 
of pregnancy.  We also examined whether any individual components of the 
STOPBANG questionnaire could be used as an alternative screening tool.  
 
Study Impact:  
This study suggests that the STOPBANG questionnaire can be used as a screening 
tool for OSA in class III obese pregnant women during the second trimester of 
pregnancy.  Loud and frequent snoring alone is also a good predictor of OSA in this 
population.     
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Introduction 
Obstructive sleep apnoea (OSA) is a sleep-related breathing disorder characterized 
by repeated episodes of upper airway collapse during sleep, resulting in episodes of 
hypoxaemia. The prevalence of symptomatic OSA in the general female population 
is 2-6%.1-2  The relationship between obesity and OSA has been well documented.3-4 
Bixler et al. reported that the presence of sleep apnoea in pre-menopausal women 
was associated exclusively with obesity.5  Physiological changes of pregnancy and 
gestational weight gain also predispose to OSA.6-8 There are few studies that have 
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looked at the risk of OSA exclusively among obese pregnant women and therefore 
the prevalence in this population is unclear.9   
 
There is a growing body of evidence that untreated OSA in pregnancy increases the 
risk of complications such as pregnancy-induced hypertension, pre-eclampsia and 
gestational diabetes mellitus.9-11  Maternal sleep-disordered breathing has also been 
associated with perinatal complications including intrauterine growth restriction, 
preterm birth, and neonatal intensive care unit admission.12-14  Testing all pregnant 
women for OSA would be costly and inefficient; and therefore a method of identifying 
women at higher risk of OSA antenatally is required. Several screening tools have 
been validated for use in identifying patients at risk of OSA in the non-pregnant 
population.  Since daytime somnolence and poor sleep quality are relatively common 
complaints of pregnancy, it is unsurprising that questionnaires which explore 
tiredness such as the Epworth Sleepiness Scale (ESS) and Berlin questionnaire are 
poor predictors of sleep-disordered breathing in pregnancy.15-17    
 
The STOPBANG questionnaire is an eight-question screening tool that has a high 
sensitivity to detect moderate to severe OSA in surgical and sleep clinic patients.18  
The probability of having OSA in these populations increases with an increasing 
STOPBANG score.  Age greater than 50 and male gender are not relevant in 
pregnant women making the maximum STOPBANG score in this population six. Two 
studies examining the use of STOPBANG in the first and third trimesters of 
pregnancy concluded that it had a good negative predictive value was not useful for 
detecting OSA.16,19   Tantrakul et al. examined the utility of STOPBANG in 72 women 
across trimesters and found it to have the best predictive value during the second 
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trimester. 20  However none of these studies looked specifically at patients with class 
III obesity.21  
 
The purpose of our study was to determine whether the STOPBANG questionnaire 
could be used to screen for OSA in class III obese pregnant women. We 
hypothesized that women with higher STOPBANG scores would be more likely to 
meet oximetry criteria for OSA.  We also proposed that modifying the STOPBANG 
questionnaire by replacing the binary “tiredness” question with an elevated ESS 
score might strengthen this association. We sought to compare the relative fit of 
seven models: STOPBANG, modified STOPBANG, and five individual 
binary questions in the STOPBANG questionnaire.  
 
Methods 
This prospective observational study was approved by the Tyne and Wear South 
Research & Ethics Committee and registered on Clinicaltrials.gov: NCT02542488. 
After obtaining written informed consent, 117 patients were enrolled at Sunderland 
Royal Hospital between February 2016 and August 2017.  Eligible women were ≥18 
years of age and had a BMI ≥40 kg/m2 at their initial midwife appointment.  We 
selected women with a high BMI with the aim of finding a greater number of 
participants who had OSA on which to base our analysis.  BMI ≥40 kg/m2 was 
specifically chosen because women in this BMI category are referred to our 
hospital’s obstetric clinic antenatally.  Any women with pre-existing sleep apnoea or 
respiratory disease were excluded.   
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Data was collected between weeks 17 to 28 of pregnancy as we were aiming to use 
the screening tool to predict OSA when women are seen at their anomaly scan or 
glucose tolerance test.  Although the prevalence of OSA increases with each 
trimester,20 screening for OSA during these routine second trimester appointments 
avoided the need for additional hospital visits and enabled time to refer women for 
potential OSA treatment before delivery.  Participants were asked the following 
questions: Do you snore loudly (loud enough to be heard through closed doors)? Do 
you often feel tired or sleepy? Has anyone observed you stop breathing? Do you 
have or are you being treated for high blood pressure?   They were then given the 
Epworth Sleepiness Scale (ESS) questionnaire to complete and a research midwife 
recorded their age and measured their BMI, non-invasive blood pressure and neck 
circumference.  STOPBANG scores were calculated for all participants.  The ESS 
was calculated and a score of ≥ 10 was included as a ‘point’ in the Modified 
STOPBANG score (see Figure 1: STOP and Modified Stop Questions).  
 
After this appointment all participants were given a Masimo Rad-8 pulse oximeter 
(part number 9019) to use at home for one night and return the following day.  This 
device, which records oxygen saturations and pulse rate, is used routinely by our 
institution’s respiratory department to help diagnose OSA. The oximetry data was 
analysed using the Stowood Visi download software.   A desaturation was defined as 
a drop in the oxygen saturations of ≥ 4% from the baseline.  These desaturations 
can result in the development of significant complications due to sympathetic 
activation and oxidative stress.22  The oxygen desaturation index (ODI) was 
calculated from the average number of oxygen desaturations per hour.23 All of the 
oximetry recordings were reviewed by a pulmonary physiologist to ensure that they 
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were adequate.  A minimum of four hours continuous oximetry measurements were 
required for the sleep study to be deemed acceptable for inclusion.  
 
We defined suspected OSA as ≥ 5 oxygen desaturation events per hour in 
accordance with the American Academy of Sleep Medicine guideline.24 All patients 
with an ODI ≥ 5 were contacted to inform them of the result and offered referral to a 
sleep physician for further assessment.   
 
Statistical Analysis 
All analyses were performed using Stata software (StataCorp, 2015. Stata Statistical 
Software: Release 14, College Station, TX, USA: StataCorp LP). A formal sample 
size estimation was not conducted a priori, due to the lack of a robust and sufficiently 
precise estimate of the prevalence of OSA in class III obese pregnant women at this 
gestation. Post-study, using the derived log odds ratio and its standard error, we 
calculate that our study had ~90% power to detect a small odds ratio of 2.5 for a 1-
unit increment in STOPBANG score (with one-sided P=0.05). Given the small 
absolute number of events (n=15), the odds ratio and predicted probabilities of 
having OSA were derived using logistic regression with penalised maximum 
likelihood25 using the Stata ‘firthlogit’26 and ‘margins’ commands. Point estimates are 
presented together with 95% confidence intervals. 
 
We compared seven candidate models: STOPBANG total and modified STOPBANG 
total, plus five individual STOPBANG items (Snore, Tired, Observed to stop 
breathing, high blood Pressure, and Neck circumference). BMI >35 kg/m2, age >50 
years, and gender were not included as there is no variance in the data set for these 
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binary outcomes. Models were compared using an information theoretic approach 
(Akaike’s Information Criterion; AIC) with the lowest AIC value indicating the best 
relative fit. The difference in AIC from the ‘best’ model (i.e. the model with the lowest 
AIC value; AIC difference = 0) was evaluated according to the following scale: 0–2, 
essentially equivalent model; 2–7, plausible alternative; 7–14, weak support; greater 
than 14, no empirical support.27 Results are presented for the model with the best 
relative fit from the candidate models compared, as well as for any model found to 
be ‘essentially equivalent’.  
 
As it has been reported that the number of disordered breathing events is a better 
measure than the rate at which these events occur (ODI or respiratory event index)28 
we also derived the predicted total desaturation events. These predicted frequencies 
were calculated following a negative binomial regression model, providing the 
incidence rate ratio (ratio of counts) for a 1-unit increment in the predictor 
(STOPBANG or modified STOPBANG, or a 'yes' vs. a 'no' for a binary question).  
 
Results 
A total of 132 eligible women were approached to participate in the study.  Of the 
117 recruited, 18 were excluded for the following reasons: miscarried (n=1), 
withdrew from the study (n=4), no neck circumference recorded (n=1), pulse 
oximeter not used (n=3), inadequate oximetry recording (n=2), not seen before end 
of second trimester (n=7).  
 
Sample characteristics for the 99 women that completed the study are displayed in 
Table 1. Fifteen participants had an ODI ≥ 5, all having results within the range for 
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mild OSA (5-15).29  Total STOPBANG and Modified STOPBANG scores ranged from 
1-5. A total of 41 women (41%) had a neck circumference >40 cm, 84% (n=84) 
answered yes to the ‘tired’ question, and 3% (n=3) had high blood pressure.  
Amongst those women with ODI ≥5, the incidence of snoring was 87% (n=13) and 
20% (n=3) reported that they had been observed to stop breathing while asleep.  
 
The odds ratio for the logistic regression of OSA on STOPBANG was 2.20 (95% 
confidence interval, 1.19 to 4.1). This finding indicates that a 1-unit increase in 
STOPBANG increases the odds of having the ODI criterion for OSA by a factor of 
2.2. Table 2 presents the predicted probabilities of having suspected OSA by 
STOPBANG score. Fewer than 1 in 10 pregnant women in the second trimester 
would be predicted to have OSA with STOPBANG scores <3. The predicted 
probability of having OSA increases to around 1 in 2 pregnant women for a 
STOPBANG score of 5, and over two-thirds with a score of 6 (the maximum for 
pregnant women). The negative binomial regression of total disordered breathing 
events on STOPBANG revealed an incidence rate ratio of 1.26 (1.06 to 1.50); for a 
1-unit increase in STOPBANG the total number of events increases by a factor of 
1.26. The predicted number of events for STOPBANG scores ranging from 0-6 is 
shown in Table 3.  
 
Table 4 shows the AIC values for the comparison of the candidate models. The 
single Snore item is the best overall model, with the standard STOPBANG total 
score ‘essentially equivalent’.  
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The odds ratio for the logistic regression of OSA on snoring (yes/no) was 6.8 (1.7 to 
28.2). The predicted probability of having OSA was 5.0 (1.5 to 15.8)% for answering 
‘no’ to the snoring question and 26.4 (16.2 to 40.1)% for ‘yes’. The negative binomial 
regression of total disordered breathing events on snoring revealed an incidence rate 
ratio of 1.69 (1.23 to 2.34). The predicted total number of events was 16 (12 to 20) 
for ‘no snoring’ and 27 (21 to 33) for ‘snoring’.  
 
Discussion 
We found that women with class III obesity who had higher STOPBANG scores mid- 
pregnancy were more likely to meet the ODI criterion for OSA.  Substituting the 
“tiredness” question with an elevated ESS score to form a Modified STOPBANG did 
not improve its predictive ability.  Of the individual components of STOPBANG, 
snoring was the best predictor of OSA.  The prevalence of OSA in this population 
diagnosed by overnight pulse oximetry was 15.2%.  This is in keeping with other 
studies that have quoted the prevalence of OSA to be 11-20% depending on 
gestation of pregnancy.30,31  
 
Based on the results in our study, fewer than 10% of women would be predicted to 
have OSA with a STOPBANG score <	3. This probability increased to 31% and 50% 
for STOPBANG scores of 4 and 5, respectively.  This is the first study to look at the 
use of STOPBANG to screen for OSA specifically in women with class III obesity 
during the second trimester.  Tantrakul et al. also observed STOPBANG to be 
predictive of OSA in pregnancy, reporting a score of ≥ 3 to have a sensitivity of 63% 
and specificity of 94% in the second trimester.20  Medical staff working in antenatal 
clinics need a quick and simple way to identify those women who should be 
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investigated for sleep-disordered breathing.  A recent survey of members of the 
Society for Obstetric Anesthesia and Perinatology found that approximately half of 
the respondents screen for OSA and of these over three quarters use the 
STOPBANG questionnaire.32 Our findings suggest that the STOPBANG 
questionnaire is a suitable screening tool for OSA during the second trimester in 
obese pregnant women.    
 
A large proportion of our study population reported feeling tired, yet only 18% had an 
ESS score above the common cut-off for excessive daytime sleepiness (>10). It has 
been well documented in the literature that tiredness and the ESS are not good 
discriminators of OSA in pregnancy1.  This may explain why we did not find the 
Modified STOPBANG score to be a superior screening tool to the original 
STOPBANG questionnaire.  
 
Just over half of our participants reported snoring on the STOP questionnaire. Other 
authors have described snoring rates of 17-34% but did not specifically look at obese 
women in the second trimester.33,34  Another reason we may have observed a higher 
snoring rate is that studies focusing on snoring conducted detailed interviews with 
precise criteria for snoring, whereas our study used simple self-reporting on the 
STOP instrument.  Another pertinent finding was that women who answered yes to 
the snoring question were more likely to have OSA.  This is in keeping with previous 
studies that have identified a positive association with snoring and sleep-disordered 
breathing in pregnancy.16,35   Smith et al. suggested that habitual snoring (snoring at 
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least 3 nights per week) could be used as a triage tool for OSA in pregnancy, 
especially among those with a BMI≥40.36   
 
We found a low prevalence of hypertension in our study population (3%).  The 
prevalence of hypertension reported by other authors ranges from 8-50%.16,30,35   
The wide variation in rates of hypertension between studies is likely to be due to the 
gestation at blood pressure was recorded.  Gestational hypertension begins after the 
20th week of pregnancy;37 hence studies of women at greater gestations are likely to 
find a higher rate of hypertension. As the mean gestation of completing the 
STOPBANG questionnaire in our study was 20 weeks, gestational hypertension 
would not have developed yet.  The prevalence of hypertension amongst our 
participants is consistent with that reported by Louis et al who studied over 2512 
women mid-pregnancy and found that 2.3% had hypertension.38    
 
Our study has some limitations.  Our study involved a small number of patients, only 
15 had an ODI≥5, and none had moderate or severe OSA.  Most participants had 
STOPBANG data and oximetry recorded at their anomaly scan at approximately 20-
weeks gestation, as we were aiming to set up a screening process for OSA during 
routine antenatal visits. It is possible that including third trimester patients would 
have given us a larger number of OSA-positive results for our analysis and perhaps 
higher ODI values.  However other studies have found that OSA, even in obese 
pregnant women, is often mild.10,30,39   
 
Another limitation is the use of portable oximetry to diagnose OSA. Overnight 
polysomnography (PSG) remains the gold standard for diagnosis of OSA.  However, 
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PSG is expensive and involves patients having to stay in a sleep laboratory 
overnight.  The ODI has been shown to be a sensitive and specific tool to detect 
OSA.23,40,41  In a study of 123 class iii obese patients, the investigators discussed the 
possibility that overnight pulse oximetry may underestimate OSA due to the 
decreased basal nocturnal saturation in obese patients.  They reported that, despite 
this, there was a strong correlation between ODI and apnoea hypopnea index.42  
However the validity of portable oximetry in a pregnant population has not been 
studied specifically.  The Watch-Pat 200 device (Itamar Medical Cesarea) is a 
portable level 3 device that has been validated for use in pregnancy43 but is also 
costly and not commonly available in the National Health Service.  As we were 
conducting a small study we chose to use the investigative tool that our institution’s 
pulmonary physiology department use routinely to diagnose OSA.  In any case, our 
prevalence and range of ODIs is similar to studies using PSG. 
 
In conclusion, this study has demonstrated that the STOPBANG questionnaire can 
help to screen for OSA in women with class III obesity during their second trimester 
of pregnancy.  However we are mindful that STOPBANG takes time to complete and 
requires additional measurements not normally conducted in an antenatal clinic. As 
snoring also helped to identify those with OSA, we would suggest a simpler 
screening method: pregnant women with class III obesity who report loud and 
frequent snoring should be referred for investigation of sleep disordered breathing.  
A larger scale study should be conducted using PSG or WATCHPAT in women 
during the second and third trimester with the aim of developing a pregnancy-specific 
screening tool for OSA.  
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Abbreviations	
	
AIC Akaike’s Information Criterion  
BMI  Body Mass Index 
ESS Epworth sleepiness scale 
ODI Oximetry desaturation index 
OSA Obstructive sleep apnoea 
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Table	1.	Sample	characteristics.	Data	are	mean	(SD)	unless	stated.	(n=99).		
Variable	 Summary	statistic	
Age	(years)	 28.1	(5.4)	
BMI	at	booking	(kg/m2) 	 44.4	(4.5)	
Gestation	(STOPBANG	data	collection)	in	
weeks	
20.1	(2.6)	
Gestation	(oximetry)	in	weeks	 20.9	(2.0)	
Snoring	(%)	 50.5	
Tired	(%)	 83.8	
Observed	to	stop	breathing	(%)	 8.1	
Systolic	blood	pressure	(mmHg)	 117	(10)	
Diastolic	blood	pressure	(mmHg)	 71	(8)	
Neck	circumference	(cm)	 40.1	(2.8)	
STOP-BANG	total		 2.7	(0.9)		
Epworth	sleepiness	scale	score	 6.3	(4.0)	
Presumed	OSA	from	oximetry	result	(%)	 15.2	
ODI	(median,	interquartile	range,	range)	 2.2	(0.9	to	3.7)	(0	to	11.9)	
Oximetry	duration	(hours)	 8.2	(1.7)	
Total	number	of	disordered	breathing	events	
(median,	interquartile	range,	range)	
17	(8	to	32)	(0	to	76)	
OSA,	obstructive	sleep	apnoea;	ODI,	oxygen	desaturation	index;	BMI,	body	mass	index.		
	
	
Table	2.	Predicted	probability	of	obstructive	sleep	apnoea	by	STOPBANG	score.	
STOPBANG	score	
Predicted	Probability	(%)	
(95%	confidence	interval)	
0	 1.8	(0.2	to	12.2)	
1	 4.0	(1.0	to	14.6)	
2	 8.3	(3.6	to	18.1)	
3	 16.7	(10.3	to	26.1)	
4	 30.7	(16.9	to	49.2)	
5	 49.5	(21.2	to	78.1)	
6	 68.4	(25.0	to	93.4)	
	
	
Table	3.	Predicted	number	of	total	disordered	breathing	events	by	STOPBANG	score.		
STOPBANG	score	
Predicted	number	of	events	
(95%	confidence	interval)	
0	 11	(6	to	17)	
1	 14	(9	to	19)	
2	 18	(14	to	22)	
3	 23	(19	to	27)	
4	 29	(21	to	37)	
5	 36	(20	to	52)	
6	 46	(18	to	73)	
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Table	4.	Comparison	of	the	seven	candidate	models	for	the	prediction	of	OSA	 	
 
Variable	 AIC*	
AIC	difference	vs.	
best	model	
Inference	
STOPBANG	total	 76.4	 1.4	 Essentially	equivalent	
Modified	STOPBANG	total	 80.1	 5.1	 Plausible	alternative	
Snore	 75.0	 0	 Best	model	
Tired	 85.1	 10.1	 Weak	support	
Observed	to	stop	breathing	 82.6	 7.6	 Weak	support	
High	blood	Pressure	 85.5	 10.5	 Weak	support	
Neck	circumference	 84.1	 9.1	 Weak	support	
*AIC;	Akaike’s	Information	Criterion	–	lowest	value	=	best	relative	fit.	AIC	difference	was	
evaluated	according	to	the	following	scale:	0–2,	essentially	equivalent	model;		
2–7,	plausible	alternative;	7–14,	weak	support;	greater	than	14,	no	empirical	support.			
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Figure	1.	STOP	&	Modified	STOP	Questions		
	
 
	
 
STOP	Questions	
	
S	-	Do	you	Snore	loudly?		
(louder	than	talking	or	loud	enough	to	be	heard	through	closed	doors)	
	
T	-	Do	you	often	feel	Tired	or	sleepy?	
	
O	-	Has	anyone	Observed	you	stop	breathing?	
	
P	-	Do	you	have	or	are	you	being	treated	for	high	blood	Pressure?	
	
Score 1 for each ‘Yes’ answer 
	
	
Modified	STOP	Questions		
	
S	-	Do	you	Snore	loudly?		
(louder	than	talking	or	loud	enough	to	be	heard	through	closed	doors)	
	
T	–	Is	your	Epworth	sleepiness	scale	score	(a	measure	of	Tiredness)	≥	10	
	
O	-	Has	anyone	Observed	you	stop	breathing?	
	
P	-	Do	you	have	or	are	you	being	treated	for	high	blood	Pressure?	
	
Score 1 for each ‘Yes’ answer 
	
	
